文献速递哮喘

鞘脂相关儿童哮喘内型的特征与机制

Characteristics and Mechanisms of a Sphingolipid-associated Childhood Asthma Endotype.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

该研究基于COPSAC2010出生队列超500名儿童的多组学数据,整合血浆鞘脂代谢物、17q21基因型及鼻部SPT基因表达,探索鞘脂相关儿童哮喘内型。发现6月龄时神经酰胺和鞘磷脂浓度较低与3岁前哮喘风险增加相关,6岁时关键鞘磷脂浓度较低与气道阻力增加相关,且与17q21基因型及SPT表达相关,但未通过FDR校正。

要点

  • 6月龄时神经酰胺和鞘磷脂浓度较低与3岁前哮喘风险增加相关
  • 6岁时关键鞘磷脂浓度较低与气道阻力增加相关,且依赖17q21基因型和鼻部SPT表达
  • 上述关联未通过FDR<0.05阈值,需谨慎解读

核心结论

  • 该探索性研究提示存在一种早发且气道阻力增加的儿童哮喘内型,以鞘脂浓度降低为特征,并与17q21基因变异及SPT酶表达相关。

研究设计与样本

  • 研究使用COPSAC2010出生队列中超过500名儿童在6月龄和6岁时的非靶向液相色谱-质谱血浆代谢组学数据,聚焦鞘脂,并整合17q21基因型和鼻部SPT基因表达。
  • 在独立VDAART队列中寻求复制。

主要发现

  • 6月龄时神经酰胺和鞘磷脂浓度较低与3岁前发生哮喘的风险增加相关,该关联在VDAART队列中也被观察到。
  • 6岁时关键鞘磷脂(如鞘氨醇-1-磷酸)浓度较低与气道阻力增加相关。
  • 该关系依赖于17q21基因型和鼻部SPT基因表达,基因型与鞘磷脂浓度之间以及基因型与SPT表达之间存在显著交互作用,其中较低的鞘磷脂浓度和降低的SPT表达与风险等位基因数量增加相关。
  • 上述发现未通过错误发现率<0.05的阈值。

局限性

  • 研究为探索性研究,相关发现未通过错误发现率<0.05的阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: A link among sphingolipids, 17q21 genetic variants, and childhood asthma has been suggested, but the underlying mechanisms and characteristics of such an asthma endotype remain to be elucidated.Objectives: To study the sphingolipid-associated childhood asthma endotype using multiomic data.Methods: We used untargeted liquid chromatography-mass spectrometry plasma metabolomic profiles at the ages of 6 months and 6 years from more than 500 children in the COPSAC2010 (Copenhagen Prospective Studies on Asthma in Childhood) birth cohort focusing on sphingolipids, and we integrated the 17q21 genotype and nasal gene expression of SPT (serine palmitoyl-CoA transferase) (i.e., the rate-limiting enzyme in de novo sphingolipid synthesis) in relation to asthma development and lung function traits from infancy until the age 6 years. Replication was sought in the independent VDAART (Vitamin D Antenatal Asthma Reduction Trial) cohort.Measurements and Main Results: Lower concentrations of ceramides and sphingomyelins at the age of 6 months were associated with an increased risk of developing asthma before age 3, which was also observed in VDAART. At the age of 6 years, lower concentrations of key phosphosphingolipids (e.g., sphinganine-1-phosphate) were associated with increased airway resistance. This relationship was dependent on the 17q21 genotype and nasal SPT gene expression, with significant interactions occurring between the genotype and the phosphosphingolipid concentrations and between the genotype and SPT expression, in which lower phosphosphingolipid concentrations and reduced SPT expression were associated with increasing numbers of at-risk alleles. However, the findings did not pass the false discovery rate threshold of <0.05.Conclusions: This exploratory study suggests the existence of a childhood asthma endotype with early onset and increased airway resistance that is characterized by reduced sphingolipid concentrations, which are associated with 17q21 genetic variants and expression of the SPT enzyme.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Rago D, Pedersen CT, Huang M, et al. Characteristics and Mechanisms of a Sphingolipid-associated Childhood Asthma Endotype. Am J Respir Crit Care Med. 2021. PMID: 33535020. doi:10.1164/rccm.202008-3206OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。